Delivery Order SPE2DB20D2104-SPE2DB25FNBFU
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Venclexta 100 mg tablets (120-count units) with a ceiling value of $9,728.17 and an ultimate completion date of June 23, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a child delivery order under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 30, 2025, for the supply of Venclexta 100 mg tablets in quantities of 120 units, with a ceiling value of $9,728.17 and an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a pharmaceutical supply transaction supporting federal medical procurement needs. The work is to be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Venclexta 100 mg tablets in a quantity of 120 units, with a contract ceiling value of $9,728.17. This is a firm fixed-price delivery order with an ultimate completion date of September 2, 2025, and was awarded without a set-aside designation through competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 2, 2025, for the supply of Venclexta 100 mg tablets (120 count) at a ceiling value of $9,728.17. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded contract. The order is set for ultimate completion by May 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Venclexta 100 mg tablets in a quantity of 120 units, with a ceiling value of $9,728.17. This is a firm fixed-price delivery order with an ultimate completion date of September 24, 2025, and represents a competitive award with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Venclexta 100 mg tablets (120-count units) valued at $9,728.17, with completion scheduled for October 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Venclexta 100 mg tablets (120 count) valued at $9,728.17. This firm fixed-price delivery order, awarded on June 16, 2025, represents fulfillment under the company's larger pharmaceutical supply contract with DLA. The award was made through open competition with no set-aside designation, with ultimate completion scheduled for July 9, 2025. AmerisourceBergen will fulfill this order from its...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,728.17 for Venclexta 100 mg tablets (120-count units) on August 4, 2025, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price contract reflects no set-aside designation and represents a routine pharmaceutical supply delivery to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Venclexta 100 mg tablets in a quantity of 120 units, with a ceiling value of $9,728.17. This is a firm fixed price delivery order with an ultimate completion date of August 25, 2025, and does not utilize a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order valued at $9,728.17 to AmerisourceBergen Drug Corp for the supply of Venclexta 100 mg tablets (120 count) on September 18, 2025, with completion targeted for October 9, 2025. This firm fixed price delivery order represents a non-competitive, non-set-aside award to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken and is part of the...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FNBFUDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for supply of Venclexta 100 mg tablets (120-count units) with a ceiling value of $9,728.17. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of October 15, 2025, and represents a child order under a larger contract vehicle. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military and veteran healthcare systems. The company's SPE2DX contract serves as a global pharmaceutical support vehicle enabling delivery of specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains to support Defense Health Agency operations and other federal healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.7k | 9/23/25 |